[Use of rovamycin and amox-clav in patients with infectious-inflammatory pathology of the ORL organs].
Clinical and microbiological findings led the authors to the conclusion that antibacterial drugs rovamycin and amox-clav are active against ENT infection and inflammation. The trial included 69 and 42 patients given rovamycin and amox-clav, respectively.
Kriukov
A I
AI
Poliakova
T S
TS
Ogorodnikov
D S
DS
Gaĭvoronskaia
G A
GA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D001419:Bacteria / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy*; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007249:Inflammation; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy* / Q000382:microbiology; D015572:Spiramycin / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D015572:Spiramycin; D000658:Amoxicillin
Primenenie rovamitsina i amoksiklava u patsientov s infektsionno-vospalitel'noĭ patologieĭ LOR-organov.